SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-011893
Filing Date
2022-03-28
Accepted
2022-03-28 07:15:18
Documents
14
Period of Report
2022-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K_EARNINGS RELEASE_MARCH2022 itrm-8k_20220328.htm   iXBRL 8-K 40977
2 EX-99.1 itrm-ex991_24.htm EX-99.1 329969
3 GRAPHIC ghjekebvzre5000001.jpg GRAPHIC 7989
  Complete submission text file 0001564590-22-011893.txt   535071

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA itrm-20220328.xsd EX-101.SCH 5693
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE itrm-20220328_lab.xml EX-101.LAB 20871
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itrm-20220328_pre.xml EX-101.PRE 12465
8 EXTRACTED XBRL INSTANCE DOCUMENT itrm-8k_20220328_htm.xml XML 3813
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 22773174
SIC: 2834 Pharmaceutical Preparations